Refractory hyperkalaemic cardiac arrest - What to do first: Treat the reversible cause or initiate E-CPR?

Resuscitation. 2019 Sep:142:81. doi: 10.1016/j.resuscitation.2019.07.014. Epub 2019 Jul 19.

Authors

Uwe Klingkowski¹, Gabriele Kropshofer², Roman Crazzolara², Thomas Schachner², Gerard Cortina²

Affiliations

¹ Medical University of Innsbruck, Department of Pediatrics, Pediatric Intensive Care Unit, Anichstr. 35, 6020 Innsbruck, Austria. Electronic address: uwe.klingkowski@tirol-kliniken.at.
² Medical University of Innsbruck, Department of Pediatrics, Pediatric Intensive Care Unit, Anichstr. 35, 6020 Innsbruck, Austria.

PMID: 31330202
DOI: 10.1016/j.resuscitation.2019.07.014

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Advanced Cardiac Life Support / methods*
Antineoplastic Agents, Immunological / administration & dosage
Antineoplastic Agents, Immunological / adverse effects
Burkitt Lymphoma / drug therapy
Child, Preschool
Extracorporeal Membrane Oxygenation / methods*
Female
Glucocorticoids / administration & dosage
Glucocorticoids / adverse effects*
Heart Arrest* / etiology
Heart Arrest* / therapy
Humans
Hyperkalemia* / etiology
Hyperkalemia* / therapy
Renal Dialysis / methods*
Rituximab / administration & dosage
Rituximab / adverse effects*
Time-to-Treatment
Treatment Outcome
Tumor Lysis Syndrome / blood
Tumor Lysis Syndrome / etiology
Tumor Lysis Syndrome / therapy
Ventricular Fibrillation / etiology
Ventricular Fibrillation / therapy

Substances

Antineoplastic Agents, Immunological
Glucocorticoids
Rituximab